Stay updated on Avelumab Entinostat in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab Entinostat in Ovarian Cancer Clinical Trial page.

Latest updates to the Avelumab Entinostat in Ovarian Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAn NIH-wide notice about the terminology shift from “Artificial Intelligence” to “Super Intelligence” appears above the unchanged 403 error page. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe footer shows an updated ClinicalTrials.gov site revision, from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check36 days agoChange DetectedThe study record page now displays a 403 Forbidden message, making the study details unavailable to visitors. This reflects a site access issue rather than a content update.SummaryDifference20%

- Check43 days agoChange DetectedA new revision tag v3.7.0 was added and the previous v3.6.6 revision was removed, signaling a page version update.SummaryDifference0.0%

- Check57 days agoChange DetectedFooter revision badge updated from v3.6.5 to v3.6.6, reflecting a site maintenance update. There is no change to the study details, eligibility criteria, or how users interact with the page.SummaryDifference0.0%

- Check78 days agoChange DetectedThe page was updated to revision v3.6.5, representing the latest version of the page after the previous revision v3.6.4.SummaryDifference0.0%

Stay in the know with updates to Avelumab Entinostat in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab Entinostat in Ovarian Cancer Clinical Trial page.